Revenue declined 3% to ZAR 14.9bn, but EBITDA rose 5% and operating profit 10% on strong execution. PG Bison and Feltex drove growth, while Safripol and Optix underperformed. Net debt fell 8%, and further reductions are targeted, though H2 is expected to be softer.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.